PETS — PetMed Express Share Price
0.000.00%
Last trade - 00:00- $87.97m
- $34.50m
- $256.86m
- 86
- 93
- 21
- 74
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 75.64 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | 14.42% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.77 | ||
| Price to Tang. Book | 1.19 | ||
| Price to Free Cashflow | 5.05 | ||
| Price to Sales | 0.33 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -8.81% | ||
| Return on Equity | -4.83% | ||
| Operating Margin | -3.86% | ||
Financial Summary
| Year End 31st Mar | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 283.42 | 284.13 | 309.21 | 273.42 | 256.86 | 284.91 | 305.56 | -1.27% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +8.13 | -30.01 | +18.01 | -31.86 | -91.9 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
PetMed Express, Inc., doing business as PetMeds, is a direct-to-consumer pet pharmacy. The Company is an online provider of prescription and non-prescription medications, food, supplements, supplies and vet services for dogs, cats, and horses. It markets and sells directly to consumers through its websites, toll-free numbers, and mobile applications. Its product line contains approximately 15,000 SKUs of pet medications, health products, and supplies. The Company offers various pet supplies, including food, beds, crates, stairs and other pet supplies. PetMeds products include Non-Prescription Medications (OTC) and supplies, and Prescription Medications (Rx). OTC and supplies include flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies. Rx includes heartworm and flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications.
Directors
- Gian Fulgoni NEC
- Mathew Hulett PRE (51)
- Bruce Rosenbloom CFO (52)
- Mark Moseley CTO
- Dan Pingree CMO
- Leslie Campbell IND (62)
- Ronald Korn IND (81)
- Jodi Watson IND (56)
- Last Annual
- March 31st, 2023
- Last Interim
- September 30th, 2023
- Incorporated
- January 29th, 1996
- Public Since
- April 6th, 2000
- No. of Shareholders
- 134
- No. of Employees
- 302
- Sector
- Food & Drug Retailing
- Industry
- Consumer Defensives
- Exchange
- NASDAQ Global Select Market
- Shares in Issue
- 21,147,006
- Address
- 420 South Congress Avenue, DELRAY BEACH, 33445
- Web
- https://www.1800petmeds.com/
- Phone
- +1 5614264444
- Contact
- Brian Prenoveau
- Auditors
- RSM US LLP
Upcoming Events for PETS
Q1 2024 Petmed Express Inc Earnings Release
Petmed Express Inc Annual Shareholders Meeting
Similar to PETS
Caseys General Stores
NASDAQ Global Select Market
Chefs' Warehouse
NASDAQ Global Select Market
Grocery Outlet Holding
NASDAQ Global Select Market
Ingles Markets
NASDAQ Global Select Market
SpartanNash Co
NASDAQ Global Select Market
FAQ
What is the PetMed Express share price?
As of Today at 19:16 UTC, shares in PetMed Express are trading at $4.16. This share price information is delayed by 15 minutes.
How has the PetMed Express share price performed this year?
Shares in PetMed Express last closed at $4.16 and the price had moved by -73.45% over the past 365 days. In terms of relative price strength the PetMed Express share price has underperformed the S&P500 Index by -78.56% over the past year.
What are the analyst and broker recommendations for PetMed Express?
The overall consensus recommendation for PetMed Express is Hold. You can view the full broker recommendation list by unlocking its StockReport.
What is the PetMed Express dividend yield?
The PetMed Express dividend yield is 28.85% based on the trailing twelve month period.
Does PetMed Express pay a dividend?
Last year, PetMed Express paid a total dividend of $1.20, and it currently has a trailing dividend yield of 28.85%. We do not have any data on when PetMed Express is to next pay dividends.
When does PetMed Express next pay dividends?
We do not have data on when PetMed Express is to next pay dividends. The historic dividend yield on PetMed Express shares is currently 28.85%.
How do I buy PetMed Express shares?
To buy shares in PetMed Express you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of PetMed Express?
As of the previous close price of $4.16, shares in PetMed Express had a market capitalisation of $87.97m.
Where are PetMed Express shares listed?
Here are the trading details for PetMed Express:
- Country of listing: United States
- Exchange: NSQ
- Ticker Symbol: PETS
What kind of share is PetMed Express?
Based on an overall assessment of its quality, value and momentum PetMed Express is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a PetMed Express share price forecast for 2024?
The analyst consensus target price for shares in PetMed Express is $7.75. That is 86.3% above the last closing price of $4.16.
Analysts covering PetMed Express currently have a consensus Earnings Per Share (EPS) forecast of -$0.05 for the next financial year.
What is the trend in the PetMed Express share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like PetMed Express. Over the past six months, its share price has underperformed the S&P500 Index by -63.39%.
As of the last closing price of $4.16, shares in PetMed Express were trading -52.08% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the PetMed Express PE Ratio?
The PetMed Express PE ratio based on its reported earnings over the past 12 months is 75.64. The shares last closed at $4.16.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of PetMed Express?
PetMed Express' management team is headed by:
- Gian Fulgoni - NEC
- Mathew Hulett - PRE
- Bruce Rosenbloom - CFO
- Mark Moseley - CTO
- Dan Pingree - CMO
- Leslie Campbell - IND
- Ronald Korn - IND
- Jodi Watson - IND